Herbs (Global Traditional) · European
Sweet Woodruff (Galium odoratum) (Galium odoratum)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Sweet woodruff (Galium odoratum) contains coumarin as its primary bioactive compound, which provides anticoagulant and anti-inflammatory properties. The herb also contains flavonoids like quercetin and kaempferol that contribute to its antioxidant activity.
Sweet woodruff (Galium odoratum) is a perennial herb native to Europe, western Asia, and North Africa, commonly found in moist, shaded woodlands. The aerial parts (leaves and stems) are harvested and typically dried to increase coumarin content through enzymatic conversion from melilotoside. Traditional extraction methods include drying the herb or using solvent extraction with ethanol or water.
No human clinical trials, RCTs, or meta-analyses were identified for Galium odoratum in the available research. Evidence is limited to in vitro studies, animal models, and traditional use documentation. The anti-inflammatory properties referenced (Mascolo et al., 1987) lack specified human trial details or PubMed identifiers.
No clinically studied dosage ranges available due to absence of human trials. Traditional use suggests 3-3.5 g of fresh woodruff per liter of beverage. Coumarin content varies significantly with drying (24.8-77.46% in volatiles). No standardized extracts have been established for clinical use. Consult a healthcare provider before starting any new supplement.
Sweet Woodruff (Galium odoratum) is a low-calorie aromatic herb used primarily in small culinary and medicinal quantities, meaning macronutrient contributions to diet are negligible. Key bioactive compounds drive its nutritional and pharmacological interest: Coumarins are the dominant class, with coumarin (1,2-benzopyrone) present at approximately 0.6–1.0% dry weight in flowering aerial parts, alongside the glycoside asperuloside (an iridoid glycoside) at roughly 0.05–0.1% dry weight — asperuloside hydrolyzes to release coumarin upon drying or fermentation, which accounts for the herb's characteristic vanilla-hay scent. Flavonoids are well-documented constituents, including quercetin and kaempferol (as glycosides) at a combined estimated 0.3–0.8% dry weight, contributing to antioxidant capacity; these flavonols have moderate bioavailability when consumed as glycosides, requiring intestinal hydrolysis before absorption. Tannins (gallotannins) are present at approximately 1–2% dry weight, providing astringent properties but potentially reducing mineral bioavailability if consumed in quantity. Iridoids beyond asperuloside include monotropein at trace levels. Organic acids, particularly citric and malic acid, are present in small amounts. Vitamin content is not formally characterized in nutritional databases, though as a leafy green herb, modest amounts of vitamin C and pro-vitamin A carotenoids are plausible but unquantified. Mineral data is sparse; as with most leafy herbs, potassium, calcium, and magnesium are likely present at low-to-moderate levels but no reliable quantitative data exists. Fiber content is negligible at typical use doses. Bioavailability caveat: coumarin is readily absorbed but undergoes significant first-pass hepatic metabolism; at high doses it is hepatotoxic, and the European Food Safety Authority has established a tolerable daily intake of 0.1 mg/kg body weight, meaning culinary use (e.g., May wine) should remain occasional and moderate.
Sweet woodruff's coumarin compounds inhibit vitamin K-dependent clotting factors and suppress inflammatory cytokine production through NF-κB pathway modulation. The flavonoids quercetin and kaempferol scavenge free radicals and upregulate antioxidant enzymes like superoxide dismutase. Coumarin derivatives also demonstrate mild sedative effects by enhancing GABA neurotransmitter activity.
Human clinical data for sweet woodruff remains extremely limited, with most evidence derived from animal and in vitro studies. Mascolo et al. (1987) demonstrated anti-inflammatory effects in animal models, but sample sizes and specific outcomes were not well documented. Chemical analyses have confirmed the presence of bioactive flavonoids and coumarin compounds, but therapeutic dosages and efficacy in humans have not been established through controlled trials. Current evidence is insufficient to support specific health claims for sweet woodruff supplementation.
Sweet woodruff contains coumarin compounds that may enhance anticoagulant effects when combined with warfarin or other blood-thinning medications. Large doses could potentially cause liver toxicity due to coumarin content, though specific toxic thresholds have not been established. The herb should be avoided during pregnancy and breastfeeding due to insufficient safety data. Individuals with bleeding disorders or those scheduled for surgery should discontinue use at least two weeks prior to procedures.
